A vaccine used
to prevent cervical cancer caused by human papillomavirus
(HPV) types 16 and 18. Cervarix
is approved for use in females aged 9 to 25 years. It is a
type of bivalent vaccine (a vaccine that works against two
different viruses or other
microorganisms). Also called recombinant human papillomavirus bivalent vaccine.